173 related articles for article (PubMed ID: 31101847)
1. Affimer reagents as tools in diagnosing plant virus diseases.
Hesketh EL; Tiede C; Adamson H; Adams TL; Byrne MJ; Meshcheriakova Y; Kruse I; McPherson MJ; Lomonossoff GP; Tomlinson DC; Ranson NA
Sci Rep; 2019 May; 9(1):7524. PubMed ID: 31101847
[TBL] [Abstract][Full Text] [Related]
2. The structures of a naturally empty cowpea mosaic virus particle and its genome-containing counterpart by cryo-electron microscopy.
Hesketh EL; Meshcheriakova Y; Thompson RF; Lomonossoff GP; Ranson NA
Sci Rep; 2017 Apr; 7(1):539. PubMed ID: 28373698
[TBL] [Abstract][Full Text] [Related]
3. Cowpea Mosaic Virus Nanoparticles and Empty Virus-Like Particles Show Distinct but Overlapping Immunostimulatory Properties.
Wang C; Beiss V; Steinmetz NF
J Virol; 2019 Nov; 93(21):. PubMed ID: 31375592
[TBL] [Abstract][Full Text] [Related]
4. Combining high-resolution cryo-electron microscopy and mutagenesis to develop cowpea mosaic virus for bionanotechnology.
Meshcheriakova Y; Durrant A; Hesketh EL; Ranson NA; Lomonossoff GP
Biochem Soc Trans; 2017 Dec; 45(6):1263-1269. PubMed ID: 29101307
[TBL] [Abstract][Full Text] [Related]
5. Genetic engineering and characterization of Cowpea mosaic virus empty virus-like particles.
Sainsbury F; Saxena P; Aljabali AA; Saunders K; Evans DJ; Lomonossoff GP
Methods Mol Biol; 2014; 1108():139-53. PubMed ID: 24243247
[TBL] [Abstract][Full Text] [Related]
6. Crystal Structure and Proteomics Analysis of Empty Virus-like Particles of Cowpea Mosaic Virus.
Huynh NT; Hesketh EL; Saxena P; Meshcheriakova Y; Ku YC; Hoang LT; Johnson JE; Ranson NA; Lomonossoff GP; Reddy VS
Structure; 2016 Apr; 24(4):567-575. PubMed ID: 27021160
[TBL] [Abstract][Full Text] [Related]
7. Cowpea Mosaic Virus Outperforms Other Members of the Secoviridae as In Situ Vaccine for Cancer Immunotherapy.
Beiss V; Mao C; Fiering SN; Steinmetz NF
Mol Pharm; 2022 May; 19(5):1573-1585. PubMed ID: 35333531
[TBL] [Abstract][Full Text] [Related]
8. Stability of plant virus-based nanocarriers in gastrointestinal fluids.
Berardi A; Evans DJ; Baldelli Bombelli F; Lomonossoff GP
Nanoscale; 2018 Jan; 10(4):1667-1679. PubMed ID: 29231944
[TBL] [Abstract][Full Text] [Related]
9. Expression & immunogenicity of malaria merozoite peptides displayed on the small coat protein of chimaeric cowpea mosaic virus.
Yasawardene SG; Lomonossoff GP; Ramasamy R
Indian J Med Res; 2003 Sep; 118():115-24. PubMed ID: 14700344
[TBL] [Abstract][Full Text] [Related]
10. Human immunodeficiency virus type 1-neutralizing antibodies raised to a glycoprotein 41 peptide expressed on the surface of a plant virus.
McLain L; Porta C; Lomonossoff GP; Durrani Z; Dimmock NJ
AIDS Res Hum Retroviruses; 1995 Mar; 11(3):327-34. PubMed ID: 7786579
[TBL] [Abstract][Full Text] [Related]
11. In Vivo Fate of Cowpea Mosaic Virus In Situ Vaccine: Biodistribution and Clearance.
Affonso de Oliveira JF; Chan SK; Omole AO; Agrawal V; Steinmetz NF
ACS Nano; 2022 Nov; 16(11):18315-18328. PubMed ID: 36264973
[TBL] [Abstract][Full Text] [Related]
12. Evidence for participation of RNA 1-encoded elicitor in Cowpea mosaic virus-mediated concurrent protection.
Bruening G; Buzayan JM; Ferreiro C; Lim W
Virology; 2000 Jan; 266(2):299-309. PubMed ID: 10639316
[TBL] [Abstract][Full Text] [Related]
13. Specific Packaging of Custom RNA Molecules into Cowpea Mosaic Virus-like Particles.
Peyret H; Lomonossoff GP
Methods Mol Biol; 2022; 2480():103-111. PubMed ID: 35616860
[TBL] [Abstract][Full Text] [Related]
14. Combining Transient Expression and Cryo-EM to Obtain High-Resolution Structures of Luteovirid Particles.
Byrne MJ; Steele JFC; Hesketh EL; Walden M; Thompson RF; Lomonossoff GP; Ranson NA
Structure; 2019 Dec; 27(12):1761-1770.e3. PubMed ID: 31611039
[TBL] [Abstract][Full Text] [Related]
15. Freeze-Drying To Produce Efficacious CPMV Virus-like Particles.
Zheng Y; Lee PW; Wang C; Thomas LD; Stewart PL; Steinmetz NF; Pokorski JK
Nano Lett; 2019 Mar; 19(3):2099-2105. PubMed ID: 30801195
[TBL] [Abstract][Full Text] [Related]
16. Inactivated Cowpea Mosaic Virus in Combination with OX40 Agonist Primes Potent Antitumor Immunity in a Bilateral Melanoma Mouse Model.
Koellhoffer EC; Mao C; Beiss V; Wang L; Fiering SN; Boone CE; Steinmetz NF
Mol Pharm; 2022 Feb; 19(2):592-601. PubMed ID: 34978197
[TBL] [Abstract][Full Text] [Related]
17. Participation of the Cowpea mosaic virus protease in eliciting extreme resistance.
Fan Q; Niroula M; Feldstein PA; Bruening G
Virology; 2011 Aug; 417(1):71-8. PubMed ID: 21640367
[TBL] [Abstract][Full Text] [Related]
18. Templated mineralization by charge-modified cowpea mosaic virus.
Aljabali AA; Evans DJ
Methods Mol Biol; 2014; 1108():89-95. PubMed ID: 24243242
[TBL] [Abstract][Full Text] [Related]
19. Cowpea mosaic virus RNA-1 acts as an amplicon whose effects can be counteracted by a RNA-2-encoded suppressor of silencing.
Liu L; Grainger J; Cañizares MC; Angell SM; Lomonossoff GP
Virology; 2004 May; 323(1):37-48. PubMed ID: 15165817
[TBL] [Abstract][Full Text] [Related]
20. Endothelial targeting of cowpea mosaic virus (CPMV) via surface vimentin.
Koudelka KJ; Destito G; Plummer EM; Trauger SA; Siuzdak G; Manchester M
PLoS Pathog; 2009 May; 5(5):e1000417. PubMed ID: 19412526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
